- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Avg
|
EXHIBIT 23(a) | ||||
Consent of Independent Registered Public Accounting Firm | ||||
To the Board of Directors and Stockholders of
The Dow Chemical Company:
We consent to the incorporation by reference of our reports dated February 9, 2005 relating to the consolidated financial statements and financial statement schedule (which report expresses an unqualified opinion and includes explanatory paragraphs relating to a change in method of accounting for goodwill to conform to Statement of Financial Accounting Standards ("SFAS") Nos. 141 and 142 and a change in the method of accounting for stock-based compensation to conform to SFAS No. 123 for new grants of equity instruments to employees), of The Dow Chemical Company, and management's report on the effectiveness of internal control over financial reporting appearing in this Annual Report on Form 10-K of The Dow Chemical Company for the year ended December 31, 2004, in the following Registration Statements of The Dow Chemical Company:
Form S-3: | ||
Nos. | 33-37052 33-52980 333-101647 333-106533 | |
Form S-4: | ||
No. | 333-88443 | |
Form S-8: | ||
Nos. | 2-64560 33-21748 33-51453 33-52841 33-58205 33-61795 333-27379 333-27381 333-40271 333-43730 333-49183 333-67414 333-88443 333-91027 333-103518 333-103519 333-105080 333-115184 333-115185 | |
/s/ DELOITTE & TOUCHE LLP |
Deloitte & ToucheLLP Midland, Michigan February 18, 2005 |
224